Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Joaquin Duato
Pharma
J&J charts speedy launch of new psoriasis pill Icotyde
Protagonist Therapeutics-partnered Icotyde has the potential to become one of Johnson & Johnson's "largest products ever," CEO Joaquin Duato said.
Zoey Becker
Apr 14, 2026 11:43am
J&J chief Joaquin Duato collects sizable pay raise for 2025
Mar 11, 2026 10:55am
J&J expects revenue to reach $100B in 2026 amid Darzalex surge
Jan 21, 2026 12:01pm
J&J's Joaquin Duato 'optimistic' amid MFN discussions with Trump
Oct 14, 2025 11:52am
Big Pharmas put brave face on looming tariff threat
Jul 18, 2025 6:15am
J&J logs strong innovative drug sales despite Stelara's decline
Jul 16, 2025 11:19am
